Literature DB >> 10698505

HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis.

C A Schnabel1, Y Jacobs, M L Cleary.   

Abstract

Specific Hox genes are implicated in leukemic transformation, and their selective genetic collaboration with TALE homeobox genes, Pbx and Meis, accentuates their oncogenic potential. The molecular mechanisms underlying these coordinate functions, however, have not been characterized. In this study, we demonstrate that HoxA9 requires its Pbx interaction motif as well as its amino terminus to enhance the clonogenic potential of myeloid progenitors in vitro. We further show that HoxA9 forms functional trimeric DNA binding complexes with Pbx and Meis-like proteins on a modified enhancer. DNA binding complexes containing HoxA9 and TALE homeoproteins display cooperative transcriptional activity and are present in leukemic cells. Trimeric complex formation on its own, however, is not sufficient for HoxA9-mediated immortalization. Rather, structure-function analyses demonstrate that domains of HoxA9 which are necessary for cellular transformation are coincident with those required for trimer-mediated transcriptional activation. Furthermore, the amino terminus of HoxA9 provides essential transcriptional effector properties and its requirement for myeloid transformation can be functionally replaced by the VP16 activation domain. These data suggest that biochemical interactions between HoxA9 and TALE homeoproteins mediate cellular transformation in hematopoietic cells, and that their transcriptional activity in higher order DNA binding complexes provides a molecular basis for their collaborative roles in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698505     DOI: 10.1038/sj.onc.1203371

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

1.  Identification and characterization of Hoxa9 binding sites in hematopoietic cells.

Authors:  Yongsheng Huang; Kajal Sitwala; Joel Bronstein; Daniel Sanders; Monisha Dandekar; Cailin Collins; Gordon Robertson; James MacDonald; Timothee Cezard; Misha Bilenky; Nina Thiessen; Yongjun Zhao; Thomas Zeng; Martin Hirst; Alfred Hero; Steven Jones; Jay L Hess
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein.

Authors:  Yue Zhang; Giovanni Morrone; Jianxuan Zhang; Xiaoai Chen; Xiaoling Lu; Liang Ma; Malcolm Moore; Pengbo Zhou
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

3.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.

Authors:  Paul M Ayton; Michael L Cleary
Journal:  Genes Dev       Date:  2003-09-02       Impact factor: 11.361

4.  Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior.

Authors:  Nicole A LaRonde-LeBlanc; Cynthia Wolberger
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

5.  Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.

Authors:  Nicolas Pineault; Carolina Abramovich; Hideaki Ohta; R Keith Humphries
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

6.  Regulation of EphA8 gene expression by TALE homeobox transcription factors during development of the mesencephalon.

Authors:  Sungbo Shim; Yujin Kim; Jongdae Shin; Jieun Kim; Soochul Park
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

7.  Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.

Authors:  Glen A Bjerke; Cathy Hyman-Walsh; David Wotton
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

8.  Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.

Authors:  Sarah H Beachy; Masahiro Onozawa; Deborah Silverman; Yang Jo Chung; Mariela Martinez Rivera; Peter D Aplan
Journal:  Exp Hematol       Date:  2013-02-19       Impact factor: 3.084

9.  Protein kinase C-mediated phosphorylation of the leukemia-associated HOXA9 protein impairs its DNA binding ability and induces myeloid differentiation.

Authors:  Ulka Vijapurkar; Neal Fischbach; Weifang Shen; Christian Brandts; David Stokoe; H Jeffrey Lawrence; Corey Largman
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.